Humanwell medical response: no fentanyl like substances are exported to the United States

Recently, humanwell Pharmaceutical Group Co., Ltd (hereinafter referred to as "humanwell pharmaceutical" or "company") has paid attention to the discussion on fentanyl on the Internet, mentioned the smuggling and abuse of fentanyl substances in the United States, and the situation that both China and the United States will pay close attention to and take effective measures to deal with Fentanyl citrate injection, sufentanil citrate injection, remifentanil hydrochloride injection preparation and API (hereinafter referred to as "fentanyl series products") are the main products of the company, which are held by Yichang humanwell Pharmaceutical Co., Ltd (hereinafter referred to as "Yichang humanwell"), a holding subsidiary of the company 67% equity) production and sales, the company's fentanyl series products are described as follows: 1 The company's fentanyl series products are strictly controlled narcotic drugs China's Drug Administration Law and regulations on the administration of ephedrine drugs have made comprehensive and systematic regulations on the management of experimental research, production, marketing, use, storage, transportation and other links of such drugs Yichang humanwell strictly follows the relevant regulations, especially in the domestic circulation, the implementation of "designated production enterprises → national wholesale enterprises (qualified) → regional wholesale" Purchase and sale process of "enterprise (qualified) → medical institution" At the same time, the National Drug Administration strictly controls the production, import and export of narcotic drugs and psychotropic substances in accordance with the United Nations Convention against illicit traffic in narcotic drugs and psychotropic substances of 1988 According to relevant regulations, Yichang humanwell formulates management procedures such as management of export and sales of special management drugs and management of shipment of special management drugs, strictly controls customer qualifications and transportation routes, and reports according to the procedures stipulated by law when the import license issued by the official of the importing country, export license issued by the State Drug Administration and other materials are complete To export and sell products 2 In 2017, the sales revenue of Yichang humanwell fentanyl series products exceeded 2 billion yuan, of which the export sales revenue was about 500 yuan It is mainly exported to Sri Lanka, Ecuador, the Philippines, Turkey and other countries or regions The purchasers are all the national official purchasing agencies of the importing countries, the companies with the qualification of controlled drug operation recognized by the local authorities or the local factories with the qualification of controlled drug production Up to now, Yichang humanwell has not exported any fentanyl like substances (intermediates, raw materials or preparations) to the United States The full text of the announcement is as follows: